Artal Group’s Amgen AMGN Stock Holding History

Artal Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-150,000	Closed	-$17.4M	–	86
2014 Q1	$18.5M	Hold	150,000	–	–	0.67%	31
2013 Q4	$17.1M	Hold	150,000	–	–	0.61%	32
2013 Q3	$16.8M	Sell	150,000 -25,000	-14%	-$2.71M	0.55%	28
2013 Q2	$17.3M	Buy	+175,000	New	+$18.2M	0.54%	26

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group's AMGN Position: Q2 2014 in Review

Artal Group sold out of Amgen (AMGN) in Q2 2014, closing a stake of 150,000 shares — an estimated $17.4M sold.

Artal Group first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $18.5M in Q1 2014. 1,185 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.

Artal Group reported no remaining Amgen position as of Q2 2014 after selling out during the quarter.
Artal Group sold 150,000 Amgen shares in Q2 2014, an estimated $17.4M.
Artal Group first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
Artal Group's Amgen position peaked at $18.5M in Q1 2014.
1,185 funds tracked by Wall St. Rank held Amgen as of Q2 2014.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.